Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Is Deckers Outdoor Corporation (DECK) The Best RV and Camping Stock To Buy Now?

We recently compiled a list of the 12 Best RV and Camping Stocks To Buy Now. In this article, we are going to take a look at where Deckers Outdoor Corporation (NYSE:DECK) stands against the other RV and camping stocks.

RV Industry Outlook: Steady Growth Amid Economic Challenges?

The RV and camping industry plays a vital role in promoting outdoor recreation. It provides families and individuals with affordable travel options. Currently, the RV and camping industry is experiencing notable transformation.

A key trend driving transformation and growth in the RV and camping industry is the rise in digital nomadism, a lifestyle where individuals work remotely while traveling and use technology to perform their jobs from various locations.

According to the MBO Partners 2023 State of Independence research study, 17.3 million American workers, or 11% of the workforce, identify as digital nomads. This number has seen a significant increase since the pandemic, reflecting the growing trend of remote work that allows individuals to travel while maintaining their jobs.

As a result of this growing trend of digital nomadism, the demand for RVs and camping facilities has increased, benefiting the entire industry.

According to the RV Industry Association (RVIA), RV wholesale shipments are expected to slightly increase in 2024, reaching 324,100 units, with continued growth projected for 2025. The Fall 2024 edition of RV RoadSigns, prepared by ITR Economics, indicates that shipments could rise to the mid-300,000 unit range next year

Craig Kirby, President and CEO of RVIA, noted that while high interest rates have posed challenges for the RV market, there is optimism for steady shipments in the coming months. He highlighted that consumer interest in RV travel and camping remains strong, suggesting that as interest rates decline, the industry is well-positioned for recovery.

The new forecast estimates that 2024 RV shipments can range from 311,600 to 336,600 units, with a median of 324,100 units. For 2025, the range is expected to increase to 329,900 to 362,300 units, with a median of 346,100 units. This positive outlook reflects a resilient market despite current economic pressures.

Following Donald Trump’s re-election as President, the RV industry has expressed optimism about working with the new administration on key industry priorities. Craig Kirby, President and CEO of the RV Industry Association, congratulated Trump and emphasized their readiness to collaborate with the incoming administration and Congress. The association aims to address the needs of the RV industry, its members, and RV enthusiasts across the country. Kirby highlighted the productive relationship established during Trump’s first term, which led to significant achievements like the Great American Outdoors Act.

Phil Ingrassia, President of the RV Dealers Association (RVDA), also welcomed Trump’s return to the White House, seeing it as an opportunity to promote growth in the RV industry and encourage more Americans to explore RV travel. The RVDA plans to advocate for the passage of the Travel Trailer & Camper Tax Parity Act, which would address tax disadvantages faced by some RV dealers. Additionally, the association intends to work with its partners to advance policies that improve access to national public lands, further supporting the outdoor recreation industry.

Our Methodology

To compile our list of the 12 best RV and camping stocks to buy now, we used the Finviz and Yahoo stock screeners to find the largest RV and camping companies. We also reviewed our own rankings and consulted various online resources. From an initial pool of more than 25 RV and camping stocks, we focused on the top 12 stocks most favored by institutional investors. Data for the hedge fund sentiment surrounding each stock was taken from Insider Monkey’s database of 912 elite hedge funds. The 12 best RV and camping stocks to buy now are ranked in ascending order based on the number of hedge funds holding stakes in them as of Q2 2024.

Why do we care about what hedge funds do? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points (see more details here).

A family outdoors enjoying a camping trip, set against a backdrop of nature.

Deckers Outdoor Corporation (NYSE:DECK)

Number of Hedge Fund Holders: 52

Deckers Outdoor Corporation (NYSE:DECK) is a global leader in designing, marketing, and distributing footwear, apparel, accessories, and other outdoor equipment. It is one of the best camping stocks to buy. The company’s portfolio of brands includes UGG, HOKA, Teva, Koolaburra, and AHNU. Deckers Brands products are well-regarded among outdoor enthusiasts for their quality and performance, making them suitable for various outdoor activities, including camping.

In the second quarter of fiscal year 2025, Deckers Outdoor Corporation (NYSE:DECK) reported a significant revenue increase of 20%, reaching $1.31 billion. This growth was largely driven by strong consumer demand for HOKA and UGG products. The HOKA brand also surpassed $2 billion in revenue over the trailing twelve-month period for the very first time, showcasing its popularity among outdoor and fitness enthusiasts. New product launches, such as the Skyflow and Mach X 2, have been well-received, further enhancing HOKA’s reputation in the running and trail categories.

The company has adopted a strategic approach to expand its international presence through various channels. In Q2 2025, Deckers Outdoor Corporation (NYSE:DECK) reported that international sales grew by 33% year-over-year, indicating successful efforts to grow its international business. The company’s balance sheet is robust, with $1.22 billion in cash and no debt, providing it with the flexibility to invest in growth opportunities or enhance shareholder value.

Over the past 5 years, Deckers Outdoor Corporation (NYSE:DECK) has grown its revenue at a compound annual growth rate (CAGR) of 17%, while its net income has increased at a CAGR of 25% during the same period.

Overall, Deckers Outdoor Corporation’s (NYSE:DECK) strong financial performance and innovative product offerings make it an appealing choice for investors looking for camping stocks.

Analysts are also bullish on DECK. The 1-year median price target of $190.00 set by analysts indicates a potential upside of 11% from current levels.

According to Insider Monkey’s Q2 2024 database of over 900 hedge funds, 52 hedge funds held stakes in Deckers Outdoor Corporation (NYSE:DECK).

Overall, DECK ranks 1st on our list of the best RV and camping stocks to buy now. While we acknowledge the potential of DECK as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than DECK but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock

Disclosure: None. This article is originally published at Insider Monkey.

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

The whispers are turning into roars.

Artificial intelligence isn’t science fiction anymore.

It’s the revolution reshaping every industry on the planet.

From driverless cars to medical breakthroughs, AI is on the cusp of a global explosion, and savvy investors stand to reap the rewards.

Here’s why this is the prime moment to jump on the AI bandwagon:

Exponential Growth on the Horizon: Forget linear growth – AI is poised for a hockey stick trajectory.

Imagine every sector, from healthcare to finance, infused with superhuman intelligence.

We’re talking disease prediction, hyper-personalized marketing, and automated logistics that streamline everything.

This isn’t a maybe – it’s an inevitability.

Early investors will be the ones positioned to ride the wave of this technological tsunami.

Ground Floor Opportunity: Remember the early days of the internet?

Those who saw the potential of tech giants back then are sitting pretty today.

AI is at a similar inflection point.

We’re not talking about established players – we’re talking about nimble startups with groundbreaking ideas and the potential to become the next Google or Amazon.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 10,000% Return: This AI Stock is a Diamond in the Rough (But Our Help is Key!)

The AI revolution is upon us, and savvy investors stand to make a fortune.

But with so many choices, how do you find the hidden gem – the company poised for explosive growth?

That’s where our expertise comes in.

We’ve got the answer, but there’s a twist…

Imagine an AI company so groundbreaking, so far ahead of the curve, that even if its stock price quadrupled today, it would still be considered ridiculously cheap.

That’s the potential you’re looking at. This isn’t just about a decent return – we’re talking about a 10,000% gain over the next decade!

Our research team has identified a hidden gem – an AI company with cutting-edge technology, massive potential, and a current stock price that screams opportunity.

This company boasts the most advanced technology in the AI sector, putting them leagues ahead of competitors.

It’s like having a race car on a go-kart track.

They have a strong possibility of cornering entire markets, becoming the undisputed leader in their field.

Here’s the catch (it’s a good one): To uncover this sleeping giant, you’ll need our exclusive intel.

We want to make sure none of our valued readers miss out on this groundbreaking opportunity!

That’s why we’re slashing the price of our Premium Readership Newsletter by a whopping 70%.

For a ridiculously low price of just $29, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single restaurant meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee:  If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

 

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $29.

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!


No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a year later!

Penicillin Changed the World. This Drug Could Too

This Clinical-stage Biotech Company is Taking a Revolutionary Approach to Eradicating Many Respiratory Viruses Including a single drug to treat COVID, RSV, FLU and even Monkey-pox!

This is a clinical-stage, global leader in broad-spectrum antiviral nanomedicines who is developing therapeutic drugs that work safely and effectively, even against emerging variants!

A novel broad-spectrum antiviral

NV-387,  a drug that  treats RSV, COVID-19, Long COVID, Influenza, Bird Flu H5N1, and other respiratory viral infections as well as Monkey-pox, has successfully completed Phase 1 clinical trials in healthy subjects with no reported adverse events, even at the highest and repeated dosages. Remarkably, the company has been able to develop NV-387 for oral administration already, as well as for injectable and inhalation formulations to enable many modes of use. The Company is currently focused on advancing NV-387 into Phase II human clinical trials for the treatment of RSV infection.

Susceptible viruses CANNOT escape NV-387, even as they continue to evolve in the field into variants. Why? Because  no matter how much the virus changes, it continues to use the same host-side signature to bind to and cause infection in the hosts, and thus the nanoviricide would be anticipated to continue to be effective even as the virus mutates to generate variants.

Click to continue reading…